Table 2.

Clostridioides difficile infection (CDI) stool testing of coronavirus disease 2019 (COVID‐19) patients compared to all inpatient CDI tests in 2019

	COVID‐19 (n = 97)	All inpatient CDI tests in 2019 (n = 2984)	P‐value
Stool antigen and toxin (glutamate dehydrogenase [GDH]/ELISA immunoassay [EIA]) (n, %)
Positive	5 (5.2)	159 (5.3)	0.94
Indeterminant	10 (10.3)	288 (9.7)	0.93
Stool polymerase chain reaction (PCR) † (n, %)
Positive	0/10 (0)	121/288 (42.0)	0.02
Overall stool CDI positive (n, %)	5 (5.2)	280 (9.4)	0.16

^†Stool PCR only performed with GDH/EIA‐indeterminant samples.